Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers

NCT00914641 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: Apixaban IR
DRUG: Apixaban MR1
DRUG: Apixaban MR2
DRUG: Apixaban MR3

Sponsor

Pfizer

Collaborators

[object Object]